Lobbying Filing Details

Total Spending

$740,000

Activities

2

Lobbyists

3

Gov't Entities

4

Filing Information
Filing UUID:
7b5d1f4d-2b34-4fa8-b22c-b6efcaaa3a79
Type:
Q3 - 3rd Quarter - Report
Period:
2017 - 3rd Quarter (July 1 - Sep 30)
Date Posted:
October 20, 2017 at 3:07 PM
Income:
$0
Expenses:
$740,000
Expense Method:
Method A - Reporting amounts using LDA definitions only
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: G. Joel Baise, Director, Government Relations
Registrant
WALGREEN COMPANY

Retail Pharmacy

WASHINGTON, District of Columbia
Client
WALGREEN COMPANY
District of Columbia, United States of America
Lobbying Activities (2)
Activity 1
Pharmacy

H.R. 592 / S. 109 - The Pharmacy and Medically Underserved Areas Enhancement Act, all provisions related to amendment the Social Security Act to allow pharmacists to be reimbursed under Medicare Part B for services provided to patients in medically underserved communities, consistent with state scope of practice laws.

H.R. 3528 - The "Every Prescription Conveyed Securely Act." The bill would amend title XVIII of the Social Security Act to require e-prescribing under part D of the Medicare program of prescription drugs that are controlled substances.

Lobbyists (3)
  • ALETHIA JACKSON
  • MR. EDWARD KALETA III
  • KATHARINE TROLLER BOND
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 2
Taxation/Internal Revenue Code

Issues related to corporate tax reform; no legislation.

Lobbyists (3)
  • ALETHIA JACKSON
  • MR. EDWARD KALETA III
  • KATHARINE TROLLER BOND
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 9, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.